Holdings: PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /

PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /:

Saved in:

Bibliographic Details
Other Authors:	Li, Biaoru, Larson, Alan, Li, Shen
Format:	Electronic eBook
Language:	English
Published:	Singapore : BENTHAM Science PUBLISHER, 2020.
Subjects:	Cancer > Immunological aspects. Cancer > Immunotherapy. Tumors > Immunological aspects. Cancer > Immunologie. Cancer > Immunothérapie. Tumeurs > Immunologie. Cancer > Immunological aspects Cancer > Immunotherapy Tumors > Immunological aspects Electronic book.
Online Access:	DE-862 DE-863
Physical Description:	1 online resource
ISBN:	9811482756 9789811482755

Staff View

MARC


LEADER	00000cam a2200000 a 4500
001	ZDB-4-EBA-on1204607283
003	OCoLC
005	20241004212047.0
006	m o d
007	cr \|\|\|\|\|\|\|\|\|\|\|
008	201111s2020 si o 000 0 eng d
040			\|a YDX \|b eng \|e pn \|c YDX \|d N$T \|d OCLCO \|d EBLCP \|d OCLCF \|d UKAHL \|d OCLCQ \|d OCLCO \|d OCLCQ \|d OCLCO \|d OCLCL \|d SXB
020			\|a 9811482756 \|q (electronic bk.)
020			\|a 9789811482755 \|q (electronic bk.)
035			\|a (OCoLC)1204607283
050		4	\|a QR188.6
082	7		\|a 616.99/4079 \|2 23
049			\|a MAIN
245	0	0	\|a PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / \|c editors, Biaoru Li, Alan Larson, Shen Li.
260			\|a Singapore : \|b BENTHAM Science PUBLISHER, \|c 2020.
300			\|a 1 online resource
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
505	0		\|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion.
505	8		\|a 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION
505	8		\|a CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte
505	8		\|a GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION
505	8		\|a BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY
650		0	\|a Cancer \|x Immunological aspects. \|0 http://id.loc.gov/authorities/subjects/sh85019512
650		0	\|a Cancer \|x Immunotherapy. \|0 http://id.loc.gov/authorities/subjects/sh87002642
650		0	\|a Tumors \|x Immunological aspects. \|0 http://id.loc.gov/authorities/subjects/sh85138558
650		6	\|a Cancer \|x Immunologie.
650		6	\|a Cancer \|x Immunothérapie.
650		6	\|a Tumeurs \|x Immunologie.
650		7	\|a Cancer \|x Immunological aspects \|2 fast
650		7	\|a Cancer \|x Immunotherapy \|2 fast
650		7	\|a Tumors \|x Immunological aspects \|2 fast
655		4	\|a Electronic book.
700	1		\|a Li, Biaoru.
700	1		\|a Larson, Alan.
700	1		\|a Li, Shen.
758			\|i has work: \|a Personalized immunotherapy for tumor diseases and beyond (Text) \|1 https://id.oclc.org/worldcat/entity/E39PCFpFByVQtxHXkFK8BycCKm \|4 https://id.oclc.org/worldcat/ontology/hasWork
966	4	0	\|l DE-862 \|p ZDB-4-EBA \|q FWS_PDA_EBA \|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216 \|3 Volltext
966	4	0	\|l DE-863 \|p ZDB-4-EBA \|q FWS_PDA_EBA \|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216 \|3 Volltext
938			\|a Askews and Holts Library Services \|b ASKH \|n AH38209236
938			\|a ProQuest Ebook Central \|b EBLB \|n EBL6424217
938			\|a EBSCOhost \|b EBSC \|n 2669216
938			\|a YBP Library Services \|b YANK \|n 301732159
994			\|a 92 \|b GEBAY
912			\|a ZDB-4-EBA
049			\|a DE-862
049			\|a DE-863

Record in the Search Index

DE-BY-FWS_katkey	ZDB-4-EBA-on1204607283
_version_	1826942326585425920
adam_text
any_adam_object
author2	Li, Biaoru Larson, Alan Li, Shen
author2_role
author2_variant	b l bl a l al s l sl
author_facet	Li, Biaoru Larson, Alan Li, Shen
author_sort	Li, Biaoru
building	Verbundindex
bvnumber	localFWS
callnumber-first	Q - Science
callnumber-label	QR188
callnumber-raw	QR188.6
callnumber-search	QR188.6
callnumber-sort	QR 3188.6
callnumber-subject	QR - Microbiology
collection	ZDB-4-EBA
contents	Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY
ctrlnum	(OCoLC)1204607283
dewey-full	616.99/4079
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	616 - Diseases
dewey-raw	616.99/4079
dewey-search	616.99/4079
dewey-sort	3616.99 44079
dewey-tens	610 - Medicine and health
discipline	Medizin
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05070cam a2200553 a 4500</leader><controlfield tag="001">ZDB-4-EBA-on1204607283</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr \|\|\|\|\|\|\|\|\|\|\|</controlfield><controlfield tag="008">201111s2020 si o 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">YDX</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">YDX</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">SXB</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9811482756</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811482755</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1204607283</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR188.6</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99/4079</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /</subfield><subfield code="c">editors, Biaoru Li, Alan Larson, Shen Li.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Singapore :</subfield><subfield code="b">BENTHAM Science PUBLISHER,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Immunological aspects.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85019512</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh87002642</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumors</subfield><subfield code="x">Immunological aspects.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85138558</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Immunologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Immunothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tumeurs</subfield><subfield code="x">Immunologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Immunological aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumors</subfield><subfield code="x">Immunological aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic book.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Biaoru.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Larson, Alan.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Shen.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Personalized immunotherapy for tumor diseases and beyond (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFpFByVQtxHXkFK8BycCKm</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH38209236</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6424217</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2669216</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">301732159</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection>
genre	Electronic book.
genre_facet	Electronic book.
id	ZDB-4-EBA-on1204607283
illustrated	Not Illustrated
indexdate	2025-03-18T14:26:14Z
institution	BVB
isbn	9811482756 9789811482755
language	English
oclc_num	1204607283
open_access_boolean
owner	MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS
owner_facet	MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS
physical	1 online resource
psigel	ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA
publishDate	2020
publishDateSearch	2020
publishDateSort	2020
publisher	BENTHAM Science PUBLISHER,
record_format	marc
spelling	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li. Singapore : BENTHAM Science PUBLISHER, 2020. 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY Cancer Immunological aspects. http://id.loc.gov/authorities/subjects/sh85019512 Cancer Immunotherapy. http://id.loc.gov/authorities/subjects/sh87002642 Tumors Immunological aspects. http://id.loc.gov/authorities/subjects/sh85138558 Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects fast Cancer Immunotherapy fast Tumors Immunological aspects fast Electronic book. Li, Biaoru. Larson, Alan. Li, Shen. has work: Personalized immunotherapy for tumor diseases and beyond (Text) https://id.oclc.org/worldcat/entity/E39PCFpFByVQtxHXkFK8BycCKm https://id.oclc.org/worldcat/ontology/hasWork
spellingShingle	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY Cancer Immunological aspects. http://id.loc.gov/authorities/subjects/sh85019512 Cancer Immunotherapy. http://id.loc.gov/authorities/subjects/sh87002642 Tumors Immunological aspects. http://id.loc.gov/authorities/subjects/sh85138558 Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects fast Cancer Immunotherapy fast Tumors Immunological aspects fast
subject_GND	http://id.loc.gov/authorities/subjects/sh85019512 http://id.loc.gov/authorities/subjects/sh87002642 http://id.loc.gov/authorities/subjects/sh85138558
title	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /
title_auth	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /
title_exact_search	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /
title_full	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li.
title_fullStr	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li.
title_full_unstemmed	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li.
title_short	PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /
title_sort	personalized immunotherapy for tumor diseases and beyond
topic	Cancer Immunological aspects. http://id.loc.gov/authorities/subjects/sh85019512 Cancer Immunotherapy. http://id.loc.gov/authorities/subjects/sh87002642 Tumors Immunological aspects. http://id.loc.gov/authorities/subjects/sh85138558 Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects fast Cancer Immunotherapy fast Tumors Immunological aspects fast
topic_facet	Cancer Immunological aspects. Cancer Immunotherapy. Tumors Immunological aspects. Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects Cancer Immunotherapy Tumors Immunological aspects Electronic book.
work_keys_str_mv	AT libiaoru personalizedimmunotherapyfortumordiseasesandbeyond AT larsonalan personalizedimmunotherapyfortumordiseasesandbeyond AT lishen personalizedimmunotherapyfortumordiseasesandbeyond

Holdings

There is no print copy available.

Get full text

MARC

Record in the Search Index

There is no print copy available.

Similar Items